(HLF) Herbalife Nutrition - Ratings and Ratios
Meal Replacement, Protein Shakes, Dietary Supplements
HLF EPS (Earnings per Share)
HLF Revenue
Description: HLF Herbalife Nutrition
Herbalife Nutrition Ltd (NYSE:HLF) operates in the Personal Care Products sub‑industry, selling nutrition and weight‑management products through a global network of independent distributors; market capitalization sits just under $1 billion.
The stock trades at $9.23, marginally below its 20‑day SMA (9.36) and 50‑day SMA (9.25) while comfortably above the 200‑day SMA (7.79), indicating short‑term weakness within a longer‑term uptrend. Volatility is modest (ATR 0.48, ≈5.2 % of price) and beta (0.86) suggests lower systematic risk than the market. The 52‑week price range spans $5.11–$10.83, with average daily volume around 1.68 M shares.
Valuation is extremely compressed: trailing P/E 2.9 and forward P/E 4.4 place the stock far below sector averages, implying either significant earnings risk or a market overreaction. Absence of reported ROE signals either negative equity or inconsistent profitability, warranting scrutiny of balance‑sheet leverage and cash‑flow quality.
Key performance indicators for Herbalife include distributor count (≈4.5 M active members), net sales growth (≈8 % YoY in recent quarters), gross margin stability around 70 %, and operating cash‑flow conversion exceeding 100 % of net income. Inventory turnover remains high (> 4× annually), reflecting efficient supply‑chain management. Debt‑to‑equity is modest (< 0.5), providing headroom for dividend or share‑repurchase initiatives.
Economic drivers are anchored in global health‑and‑wellness spending, expanding middle‑class consumption in emerging markets, and the scalability of the MLM distribution model. Countervailing forces include heightened regulatory scrutiny of direct‑selling practices, currency exposure (USD‑denominated revenue vs. local‑currency costs), and commodity price volatility for protein and micronutrient inputs. Sustained demand growth and disciplined cost control are essential to translate the low valuation into upside.
HLF Stock Overview
| Market Cap in USD | 952m |
| Sub-Industry | Personal Care Products |
| IPO / Inception | 2004-12-16 |
HLF Stock Ratings
| Growth Rating | -28.8% |
| Fundamental | 59.1% |
| Dividend Rating | 8.61% |
| Return 12m vs S&P 500 | -1.40% |
| Analyst Rating | 3.25 of 5 |
HLF Dividends
Currently no dividends paidHLF Growth Ratios
| Growth Correlation 3m | 57.4% |
| Growth Correlation 12m | 47.2% |
| Growth Correlation 5y | -95.8% |
| CAGR 5y | -27.69% |
| CAGR/Max DD 5y | -0.30 |
| Sharpe Ratio 12m | -0.55 |
| Alpha | 10.62 |
| Beta | 0.040 |
| Volatility | 55.55% |
| Current Volume | 3073.4k |
| Average Volume 20d | 1868.9k |
| Stop Loss | 9.2 (-5.9%) |
| Signal | 2.53 |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (325.0m TTM) > 0 and > 6% of Revenue (6% = 295.7m TTM) |
| FCFTA 0.06 (>2.0%) and ΔFCFTA 0.25pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 0.17% (prev 4.71%; Δ -4.54pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 265.3m <= Net Income 325.0m (YES >=105%, WARN >=100%) |
| Net Debt (2.02b) to EBITDA (620.1m) ratio: 3.27 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.01 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (103.3m) change vs 12m ago 1.57% (target <= -2.0% for YES) |
| Gross Margin 78.12% (prev 76.34%; Δ 1.78pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 184.6% (prev 193.7%; Δ -9.10pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.21 (EBITDA TTM 620.1m / Interest Expense TTM 226.3m) >= 6 (WARN >= 3) |
Altman Z'' 0.14
| (A) 0.00 = (Total Current Assets 1.10b - Total Current Liabilities 1.09b) / Total Assets 2.74b |
| (B) -0.26 = Retained Earnings (Balance) -708.3m / Total Assets 2.74b |
| (C) 0.19 = EBIT TTM 499.3m / Avg Total Assets 2.67b |
| (D) -0.28 = Book Value of Equity -954.8m / Total Liabilities 3.39b |
| Total Rating: 0.14 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 59.07
| 1. Piotroski 3.50pt = -1.50 |
| 2. FCF Yield 6.10% = 3.05 |
| 3. FCF Margin 3.48% = 0.87 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda 3.52 = -2.32 |
| 6. ROIC - WACC 30.57% = 12.50 |
| 7. RoE data missing |
| 8. Rev. Trend -20.24% = -1.01 |
| 9. Rev. CAGR -1.02% = -0.17 |
| 10. EPS Trend -2.22% = -0.06 |
| 11. EPS CAGR -18.30% = -2.29 |
What is the price of HLF shares?
Over the past week, the price has changed by +0.41%, over one month by +3.60%, over three months by +23.48% and over the past year by +15.33%.
Is Herbalife Nutrition a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HLF is around 8.01 USD . This means that HLF is currently overvalued and has a potential downside of -18.1%.
Is HLF a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 2
- Sell: 1
- Strong Sell: 0
What are the forecasts/targets for the HLF price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 9 | -8% |
| Analysts Target Price | 9 | -8% |
| ValueRay Target Price | 8.7 | -10.6% |
Last update: 2025-08-27 04:39
HLF Fundamental Data Overview
CCE Cash And Equivalents = 320.9m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 2.9025
P/E Forward = 4.3956
P/S = 0.1931
P/EG = -32.8
Beta = 0.86
Revenue TTM = 4.93b USD
EBIT TTM = 499.3m USD
EBITDA TTM = 620.1m USD
Long Term Debt = 1.97b USD (from longTermDebt, last quarter)
Short Term Debt = 206.9m USD (from shortTermDebt, last quarter)
Debt = 2.18b USD (Calculated: Short Term 206.9m + Long Term 1.97b)
Net Debt = 2.02b USD (from netDebt column, last quarter)
Enterprise Value = 2.81b USD (951.7m + Debt 2.18b - CCE 320.9m)
Interest Coverage Ratio = 2.21 (Ebit TTM 499.3m / Interest Expense TTM 226.3m)
FCF Yield = 6.10% (FCF TTM 171.4m / Enterprise Value 2.81b)
FCF Margin = 3.48% (FCF TTM 171.4m / Revenue TTM 4.93b)
Net Margin = 6.59% (Net Income TTM 325.0m / Revenue TTM 4.93b)
Gross Margin = 78.12% ((Revenue TTM 4.93b - Cost of Revenue TTM 1.08b) / Revenue TTM)
Tobins Q-Ratio = -2.94 (set to none) (Enterprise Value 2.81b / Book Value Of Equity -954.8m)
Interest Expense / Debt = 2.54% (Interest Expense 55.4m / Debt 2.18b)
Taxrate = -50.12% (set to none) (from yearly Income Tax Expense: -84.9m / 169.4m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.01 (Total Current Assets 1.10b / Total Current Liabilities 1.09b)
Debt / EBITDA = 3.52 (Net Debt 2.02b / EBITDA 620.1m)
Debt / FCF = 12.72 (Debt 2.18b / FCF TTM 171.4m)
Total Stockholder Equity = -788.0m (last 4 quarters mean)
RoA = 11.88% (Net Income 325.0m, Total Assets 2.74b )
RoE = unknown (Net Income TTM 325.0m / Total Stockholder Equity -788.0m)
RoCE = 42.12% (Ebit 499.3m / (Equity -788.0m + L.T.Debt 1.97b))
RoIC = 30.57% (Ebit 499.3m / (Assets 2.74b - Current Assets 1.10b))
WACC = unknown (E(951.7m)/V(3.13b) * Re(6.16%)) + (D(2.18b)/V(3.13b) * Rd(2.54%) * (1-Tc(none)))
Shares Correlation 5-Years: 0.0 | Cagr: -0.07%
Discount Rate = 6.16% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 75.78% ; FCFE base≈165.4m ; Y1≈141.4m ; Y5≈109.7m
Fair Price DCF = 19.44 (DCF Value 2.00b / Shares Outstanding 103.1m; 5y FCF grow -17.62% → 3.0% )
Revenue Correlation: -20.24 | Revenue CAGR: -1.02%
Rev Growth-of-Growth: -1.98
EPS Correlation: -2.22 | EPS CAGR: -18.30%
EPS Growth-of-Growth: 162.3
Additional Sources for HLF Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle